1. Home
  2. CCCC vs IMMR Comparison

CCCC vs IMMR Comparison

Compare CCCC & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • IMMR
  • Stock Information
  • Founded
  • CCCC 2015
  • IMMR 1993
  • Country
  • CCCC United States
  • IMMR United States
  • Employees
  • CCCC N/A
  • IMMR N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • IMMR Computer peripheral equipment
  • Sector
  • CCCC Health Care
  • IMMR Technology
  • Exchange
  • CCCC Nasdaq
  • IMMR Nasdaq
  • Market Cap
  • CCCC 104.4M
  • IMMR 247.2M
  • IPO Year
  • CCCC 2020
  • IMMR 1999
  • Fundamental
  • Price
  • CCCC $2.26
  • IMMR $7.85
  • Analyst Decision
  • CCCC Buy
  • IMMR Strong Buy
  • Analyst Count
  • CCCC 3
  • IMMR 2
  • Target Price
  • CCCC $12.00
  • IMMR $12.25
  • AVG Volume (30 Days)
  • CCCC 1.6M
  • IMMR 519.9K
  • Earning Date
  • CCCC 07-31-2025
  • IMMR 08-19-2025
  • Dividend Yield
  • CCCC N/A
  • IMMR 2.28%
  • EPS Growth
  • CCCC N/A
  • IMMR 57.07
  • EPS
  • CCCC N/A
  • IMMR 2.04
  • Revenue
  • CCCC $39,783,000.00
  • IMMR $163,133,000.00
  • Revenue This Year
  • CCCC N/A
  • IMMR $988.71
  • Revenue Next Year
  • CCCC N/A
  • IMMR $109.72
  • P/E Ratio
  • CCCC N/A
  • IMMR $3.84
  • Revenue Growth
  • CCCC 98.56
  • IMMR 338.21
  • 52 Week Low
  • CCCC $1.09
  • IMMR $6.47
  • 52 Week High
  • CCCC $7.66
  • IMMR $13.94
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 63.62
  • IMMR 52.63
  • Support Level
  • CCCC $1.36
  • IMMR $7.62
  • Resistance Level
  • CCCC $2.17
  • IMMR $8.00
  • Average True Range (ATR)
  • CCCC 0.15
  • IMMR 0.20
  • MACD
  • CCCC 0.05
  • IMMR -0.01
  • Stochastic Oscillator
  • CCCC 67.11
  • IMMR 57.14

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: